EDGAR Filing Documents for 0001193125-13-267806

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-13-267806

Filing Date

2013-06-24

Accepted

2013-06-21 20:32:05

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d555423ds3.htm	S-3	603347
2	EX-3.2	d555423dex32.htm	EX-3.2	23773
3	EX-23.2	d555423dex232.htm	EX-23.2	1755
4	GRAPHIC	g555423g02m08.jpg	GRAPHIC	20766
5	GRAPHIC	g555423g11g35.jpg	GRAPHIC	62116
6	GRAPHIC	g555423g18n99.jpg	GRAPHIC	66991
7	GRAPHIC	g555423g18t96.jpg	GRAPHIC	41640
8	GRAPHIC	g555423g75s36.jpg	GRAPHIC	34936
9	GRAPHIC	g555423page_1.jpg	GRAPHIC	55625
10	GRAPHIC	g555423page_2.jpg	GRAPHIC	119333
11	GRAPHIC	g555423page_3.jpg	GRAPHIC	143931
12	GRAPHIC	g555423page_4.jpg	GRAPHIC	161658
13	GRAPHIC	g555423page_5.jpg	GRAPHIC	90595
	Complete submission text file	0001193125-13-267806.txt		1730393

Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121

Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700

Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)